Allergies News and Research

Latest Allergies News and Research

U.S. scientists to create coronavirus strain for human challenge trials

Now, a team of scientists in the United States plans to create a coronavirus strain that can be used for human challenge trials, a controversial type of study wherein health volunteers would be vaccinated and intentionally infected with the virus.

16 Aug 2020

Gene variants help explain link between skin condition and food allergies

Two common variants in the KIF3A gene increase the risk of young children having a dysfunctional skin barrier and developing the skin condition atopic dermatitis.

14 Aug 2020

New research delineates how genetic variations cause atopic dermatitis

New research supported by the National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the skin, promoting the development of atopic dermatitis, commonly known as eczema.

14 Aug 2020

Experimental vaccine effective at preventing pneumonia in COVID-19-infected mice

An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis.

12 Aug 2020

Public health officials are quitting or getting fired in throes of pandemic

Vilified, threatened with violence or in some cases suffering from burnout, dozens of state and local public health officials around the U.S. have resigned or have been fired amid the coronavirus outbreak, a testament to how politically combustible masks, lockdowns and infection data have become.

11 Aug 2020

COVID-19 Prevention Network announces Phase 3 trials to evaluate monoclonal antibodies

The COVID-19 Prevention Network (CoVPN) today announced two Phase 3 trials to determine whether monoclonal antibodies (mAbs) can prevent SARS-CoV-2, the virus that causes COVID-19.

11 Aug 2020

Baylor Scott & White Research Institute enrolls first patients in NIH ACTIV-3 clinical trial

On Wednesday, August 5, in Dallas, just one day after the initiative was launched by the National Institutes of Health, Baylor Scott & White Research Institute enrolled the first patient in the world for the ACTIV-3 clinical trial. A second patient was enrolled the following day.

10 Aug 2020

Study identifies five immune response markers that may predict COVID-19 patient outcomes

Galit Alter, PhD, Group Leader at the Ragon Institute of MGH, MIT and Harvard and Professor of Medicine at Harvard Medical School, and Helen Chu, MD, Associate Professor of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine, and UW Medicine physician, have recently published a paper which identifies five immune response markers which, collectively, were able to correctly classify both convalescent COVID-19 patients and those who did not survive the disease.

7 Aug 2020

New test can pinpoint which people with gonorrhea can be cured with ciprofloxacin

A test designed by UCLA researchers can pinpoint which people with gonorrhea will respond successfully to the inexpensive oral antibiotic ciprofloxacin, which had previously been sidelined over concerns the bacterium that causes the infection was becoming resistant to it.

7 Aug 2020

Frequent HIV screenings can benefit high-risk young men who have sex with men

A new study has found that HIV screening every three months compared to annually will improve clinical outcomes and be cost-effective among high-risk young men who have sex with men (YMSM) in the United States.

6 Aug 2020

Carefully engineered spike protein can help develop COVID-19 vaccine

The experimental vaccine against SARS-CoV-2 that was the first to enter human trials in the United States has been shown to elicit neutralizing antibodies and a helpful T-cell response with the aid of a carefully engineered spike protein that mimics the infection-spreading part of the virus.

6 Aug 2020

Climate change and disruption of ecosystem affect allergies, respiratory disorders

Climate change and disruption of the ecosystem have the potential to profoundly impact the human body. Xue Ming, professor of neurology at Rutgers New Jersey Medical School, who recently published a paper in the International Journal of Environmental Research and Public Health on the effects of climate change on allergies, autoimmunity and the microbiome -; the beneficial microorganisms that live on and inside the human body -; discusses how the delicate balance of the environment affects conditions such as allergies, autism, and immune disorders.

6 Aug 2020

Eosinophils contribute to antiviral host defense mechanisms during influenza

Eosinophils residing in the airways of mice respond to influenza A virus infection through alterations in surface expression of various markers necessary for migration and cellular immunity responses, according to research published in the Journal of Leukocyte Biology by researchers from Le Bonheur Children's Hospital and the University of Tennessee Health Science Center.

5 Aug 2020

Warming climate in Southern California may increase risk of West Nile outbreaks

As climate change brings hotter weather to Southern California, coastal populations from San Diego to Santa Barbara may face an increased risk of contracting West Nile virus and other mosquito-borne diseases, suggests a new study led by researchers at the University of California, Berkeley.

5 Aug 2020

Allergies News and Research

Latest Allergies News and Research

U.S. scientists to create coronavirus strain for human challenge trials

Gene variants help explain link between skin condition and food allergies

New research delineates how genetic variations cause atopic dermatitis

Experimental vaccine effective at preventing pneumonia in COVID-19-infected mice

Public health officials are quitting or getting fired in throes of pandemic

COVID-19 Prevention Network announces Phase 3 trials to evaluate monoclonal antibodies

Baylor Scott & White Research Institute enrolls first patients in NIH ACTIV-3 clinical trial

Study identifies five immune response markers that may predict COVID-19 patient outcomes

New test can pinpoint which people with gonorrhea can be cured with ciprofloxacin

Frequent HIV screenings can benefit high-risk young men who have sex with men

Carefully engineered spike protein can help develop COVID-19 vaccine

Climate change and disruption of ecosystem affect allergies, respiratory disorders

Eosinophils contribute to antiviral host defense mechanisms during influenza

Warming climate in Southern California may increase risk of West Nile outbreaks

NIH-Moderna investigational vaccine protects mice from infection with SARS-CoV-2

Laboratory test shows only 60% of COVID-19 patients develop protective antibodies

Enzyme could play key role in treating cancer, autoimmune diseases in the airway

Study: "Memory" T cells that recognize common cold coronaviruses also recognize SARS-CoV-2

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in